New Chair brings more than three decades of life sciences industry experience, with a successful track record as a biotech company board memberSignificant leadership experience will be instrumental as ...

Can autism symptoms be reversed after brain development? A new JNCASR study suggests it might be possible with a sugar-linked ...

Northwestern Medicine investigators have discovered previously unknown metabolic changes that may contribute to the ...

Historically, therapies for ASD and ID have primarily targeted managing symptoms, such as behavioral issues or communication ...

A landmark review in Nature Reviews Genetics dissects the rare and common genetic variants that shape human height. The paper ...

In a paper published in Science Bulletin, the research teams led by Professor Shunmin He, Professor Runsheng Chen, and ...

KLEF Deemed to be University takes pride in announcing a notable breakthrough in the fight against Glioblastoma Multiforme ...

Dr Emma Bolderson, from QUT's School of Biomedical Sciences, has received a $460,552 grant from the Ovarian Cancer Research ...

Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) researchers have found a potential therapy for patients suffering from autism/intellectual disability (ID) that will enable the ...

AUTX-703, a novel and potent oral KAT2A and KAT2B protein degrader, inhibits growth and induces profound, persistent cell state differentiation in SCLC models ...

New Delhi: Researchers from Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), an autonomous institute of the ...